ADAR1 Capital Management
NAMSW icon

ADAR1 Capital Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

ADAR1 Capital Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-82,857
Closed -$259K – 280
2023
Q4 		$259K Buy
+82,857
New +$162K 0.09% 76

Other funds holding NAMSW

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
GTS Securities
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return

ADAR1 Capital Management's NAMSW Position: Q1 2024 in Review

ADAR1 Capital Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 82,857 shares — an estimated $259K sold.

ADAR1 Capital Management first reported a position in NAMSW in Q4 2023 and held it in 1 quarter. The position peaked at $259K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

  • ADAR1 Capital Management reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 82,857 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $259K.
  • ADAR1 Capital Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2023 and held it in 1 quarter.
  • ADAR1 Capital Management's NewAmsterdam Pharma Warrant position peaked at $259K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on ADAR1 Capital Management's 13F filing for Q1 2024, filed 15 May 2024.